Teladoc Health Inc

Teladoc Health stock dips yet remains a key telehealth player—why investors are watching its loss‑filled metrics and upcoming Medicare changes.

Teladoc Health’s stock drops to a 52‑week low, trading at $6.28 after a $15.21 peak. Despite a negative P/E, the telehealth firm remains a key player in global digital health services, appealing to investors who want to watch its recovery and innova…

Teladoc Health stock: 52‑week high $15.21, low $6.35, P/E −5.52, P/B 0.91 – a telehealth firm with strong market cap but earnings losses, investors watch its next moves.

Teladoc Health’s stock has slid 52% from its 2025 peak, reflecting a negative P/E and below‑book valuation, yet telehealth demand keeps the company in focus for investors.

Teladoc Health Inc. announced its Chief Financial Officer will step down, but the company’s strong third-quarter performance and preliminary results have boosted investor sentiment, positioning it for future growth despite the leadership transition.

Teladoc Health Inc. reported mixed financial results for Q2 2025, but its stock remains resilient due to its diversified service offerings and the growing demand for remote healthcare solutions.

Teladoc Health, Inc. is a leading telemedicine company that offers innovative healthcare services through phone and video consultations, with a market capitalization of approximately $1.41 billion.

Teladoc Health Inc navigated a tumultuous first quarter of 2025, marked by declining revenue and stock price, but remains committed to strategic growth through acquisitions and membership expansion.